for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Natera Inc

NTRA.OQ

Latest Trade

34.01USD

Change

0.29(+0.86%)

Volume

148,905

Today's Range

33.53

 - 

34.07

52 Week Range

11.09

 - 

34.52

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
33.72
Open
33.53
Volume
148,905
3M AVG Volume
14.57
Today's High
34.07
Today's Low
33.53
52 Week High
34.52
52 Week Low
11.09
Shares Out (MIL)
70.13
Market Cap (MIL)
2,364.78
Forward P/E
-15.98
Dividend (Yield %)
--

Latest Developments

More

Natera Q2 Loss Per Share $0.48

New Proactive Study From Natera Will Test For Rejection In 3,000 Kidney Transplant Recipients

Natera Announces Pricing Of Follow-On Offering

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Natera Inc

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Industry

Biotechnology & Drugs

Contact Info

201 Industrial Rd Ste 410

+1.650.2499090

http://www.natera.com

Executive Leadership

Matthew Rabinowitz

Executive Chairman of the Board, Co-Founder

Steven Leonard Chapman

President, Chief Executive Officer, Director

Jonathan Sheena

Co-Founder, Chief Technology Officer, Director

Michael Burkes Brophy

Chief Financial Officer

Robert A. Schueren

Chief Operating Officer

Key Stats

1.83 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.2K

2018

0.3K

2019(E)

0.3K
EPS (USD)

2016

-1.860

2017

-2.560

2018

-2.220

2019(E)

-2.110
Price To Earnings (TTM)
--
Price To Sales (TTM)
8.65
Price To Book (MRQ)
25.37
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
132.84
LT Debt To Equity (MRQ)
78.97
Return on Investment (TTM)
-72.58
Return on Equity (TTM)
-44.30

Latest News

BRIEF-Natera Q1 Loss Per Share $0.61

* Q1 EARNINGS PER SHARE VIEW $-0.59 -- THOMSON REUTERS I/B/E/S

BRIEF-Natera Reports Q4 Loss Per Share $0.87

* NATERA REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

BRIEF-James Flynn Reports 5.17 Percent Passive Stake In Natera Inc

* JAMES FLYNN REPORTS 5.17 PERCENT PASSIVE STAKE IN NATERA INC AS OF DECEMBER 1 - SEC FILING Source text: (http://bit.ly/2AdxG42) Further company coverage:

BRIEF-Natera reports third quarter loss of $0.51 per share

* Q3 earnings per share view $-0.48 -- Thomson Reuters I/B/E/S

BRIEF-Natera enters into credit agreement by and between Natera and Orbimed Royalty Opportunities

* Natera - on August 8 entered into credit agreement by and between Natera as the borrower and Orbimed Royalty Opportunities II, Lp as lender - sec filing

BRIEF-Natera Q2 loss per share $0.52

* Q2 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

BRIEF-Natera Inc launches vistara to screen single-gene disorders

* Natera inc - launch of vistara, a non-invasive prenatal test (nipt) to screen single-gene disorders

BRIEF-Natera announces the appointment of Gail Marcus as member of the board of directors

* Natera announces the appointment of gail marcus as member of the board of directors Source text for Eikon: Further company coverage:

BRIEF-Natera on March 15 board increased authorized size of board to 9 members

* Natera Inc- on March 15 board increased authorized size of board to nine members - sec filing

BRIEF-Natera reports Q4 loss per share of $0.72

* Natera reports fourth quarter and fiscal year 2016 financial results

BRIEF-Natera terminates NIPT distribution agreement with Bioreference Labs

* Natera Inc. terminates NIPT distribution agreement with Bioreference Labs Source text for Eikon: Further company coverage:

BRIEF-Natera files for mixed shelf of up to $200 mln

* Files for mixed shelf of up to $200 million - SEC filing Source text: (http://bit.ly/2eWTUis) Further company coverage:

BRIEF-Natera Q3 loss per share $0.50

* FY2016 revenue view $214.5 million -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up